Inhibition of Botulinum Neurotoxin A Toxic Action In Vivo by Synthetic Synaptosome- and Blocking Antibody-Binding Regions

被引:5
作者
Atassi, M. Zouhair [1 ,2 ]
Dolimbek, Behzod Z. [1 ]
Steward, Lance E. [3 ]
Aoki, K. Roger [3 ]
机构
[1] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
[3] Allergan Pharmaceut Inc, Irvine, CA 92612 USA
关键词
Antibodies; Botulinum neurotoxin A; Mouse protection assay; Synaptosomes; Synthetic peptides; Competition; N-DOMAIN RESIDUES-449-859; HEAVY-CHAIN; B NEUROTOXIN; ANTITOXIN ANTIBODIES; PROTEIN-RECEPTOR; ANTIGENIC STRUCTURES; IMMUNE RECOGNITION; NERVE-TERMINALS; HIGH-AFFINITY; H-CHAIN;
D O I
10.1007/s10930-010-9255-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In previous studies, we showed that certain peptides of the H-N and H-C domains of the H-chain of BoNT/A bind to mouse brain synaptosomes (snps). There was either complete correspondence or overlap between peptides that bind snps and those that bind human or mouse blocking antibodies (Abs). An equimolar mixture of the overlapping peptides N5/N6/N7/N8 (residues 505-523/519-537/533-551/547-565) extended the survival time of the mice to 74 h (20%) relative to controls, which had a 50% survival time of 60 h. On the other hand, peptide N26 (residues 799-817) provided no protection (50% survival time, 58 h), but the overlapping peptide N25 (785-803) almost doubled the 50% survival time to 119 h. A mixture of the overlap N25/N26 provided an unexpected level of protection permitting 40% of the mice to survive a lethal BoNT/A dose. In the H-C domain, the overlap C23/C24 (1163-1181/1177-1195) provided no protection. Peptide C31 (1275-1296) also provided no significant protection. But an equimolar mixture of peptides C15/C16 (1051-1069/1065-1083) or peptides C18/C19/C20 (1093-1111/1107-1125/1121-1139) extended the 50% survival time by 41% (to 85 h) over controls (60 h) and was able to fully protect 20% of the mice which eventually recovered. Surprisingly, the mixture of the peptides C15/C16 and C18/C19/C20, which gave a 50% survival time of 75 h, was less protective than either peptides C15/C16 or peptides C18/C19/C20. The in vivo inhibitory activity of these peptides is discussed in relation to their location in the 3-dimensional structure of the toxin molecule and their membrane receptor binding.
引用
收藏
页码:320 / 327
页数:8
相关论文
共 54 条
  • [41] The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane
    Muraro, Lucia
    Tosatto, Silvio
    Motterlini, Lisa
    Rossetto, Ornella
    Montecucco, Cesare
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (01) : 76 - 80
  • [42] Clostridium neurotoxins influence serotonin uptake and release differently in rat brain synaptosomes
    Najib, A
    Pelliccioni, P
    Gil, C
    Aguilera, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) : 1991 - 1998
  • [43] Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA
    Nishiki, T
    Tokuyama, Y
    Kamata, Y
    Nemoto, Y
    Yoshida, A
    Sekiguchi, M
    Takahashi, M
    Kozaki, S
    [J]. NEUROSCIENCE LETTERS, 1996, 208 (02) : 105 - 108
  • [44] The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides G(T1b)/G(D1a)
    Nishiki, T
    Tokuyama, Y
    Kamata, Y
    Nemoto, Y
    Yoshida, A
    Sato, K
    Sekiguchi, M
    Takahashi, M
    Kozaki, S
    [J]. FEBS LETTERS, 1996, 378 (03) : 253 - 257
  • [45] NISHIKI T, 1994, J BIOL CHEM, V269, P10498
  • [46] The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction
    Rummel, A
    Mahrhold, S
    Bigalke, H
    Binz, T
    [J]. MOLECULAR MICROBIOLOGY, 2004, 51 (03) : 631 - 643
  • [47] Schengrund CL, 1996, J NEUROCHEM, V66, P2556
  • [48] SCHIAVO G, 1992, J BIOL CHEM, V267, P23479
  • [49] Simpson L.L., 1989, Botulinum Neurotoxin and Tetanus Toxin, P153
  • [50] SIMPSON LL, 1981, PHARMACOL REV, V33, P155